REGISTER HERE.

This course will discuss and review the latest updates in thoracic oncology including:

- COVID-19 updates surrounding vaccines for immunocompromised patients and the manifestation of lung disease after COVID
- Lung screenings and diagnostics: impact of COVID on screenings and how to motivate patients to resume routine screenings
- Novel treatments and clinical trials - where the future of treatment is heading in medical oncology and radiation oncology
There will be time allocated for Q&A.

TARGETED AUDIENCE

Specialties - FAMILY MEDICINE, INTERNAL MEDICINE - Medical Oncology, INTERNAL MEDICINE - Pulmonary Disease, OBSTETRICS AND GYNECOLOGY, RADIATION ONCOLOGY, THORACIC AND CARDIAC SURGERY

EDUCATIONAL OBJECTIVES 

• Discuss COVID-19 updates surrounding vaccines for immunocompromised patients and the manifestation of lung disease after COVID
• Review the impact of COVID on screenings and how to motivate patients to resume routine screenings
• Discuss where the future of treatment is heading in medical oncology and radiation oncology

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)

For more information please visit the official event page.